US 11690921
Delivery of target specific nucleases
granted A61KA61K38/00A61K48/0033
Quick answer
US patent 11690921 (Delivery of target specific nucleases) held by Sangamo Therapeutics, Inc. expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/00, A61K48/0033, A61K9/0019, A61K9/5123